These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29120412)

  • 1. Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemia.
    Chu YY; Ko CY; Wang SM; Lin PI; Wang HY; Lin WC; Wu DY; Wang LH; Wang JM
    Cell Death Dis; 2017 Nov; 8(11):e3167. PubMed ID: 29120412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex.
    Ko CY; Hsu HC; Shen MR; Chang WC; Wang JM
    J Biol Chem; 2008 Nov; 283(45):30919-32. PubMed ID: 18753137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells.
    Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM
    J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a.
    Chu YY; Ko CY; Wang WJ; Wang SM; Gean PW; Kuo YM; Wang JM
    Mol Neurobiol; 2016 Aug; 53(6):4173-4188. PubMed ID: 26208701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer.
    Zhou Y; Liu F; Xu Q; Yang B; Li X; Jiang S; Hu L; Zhang X; Zhu L; Li Q; Zhu X; Shao H; Dai M; Shen Y; Ni B; Wang S; Zhang Z; Teng Y
    Oncogene; 2020 Aug; 39(34):5633-5648. PubMed ID: 32661323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-584-3p inhibits gastric cancer progression by repressing Yin Yang 1- facilitated MMP-14 expression.
    Zheng L; Chen Y; Ye L; Jiao W; Song H; Mei H; Li D; Yang F; Li H; Huang K; Tong Q
    Sci Rep; 2017 Aug; 7(1):8967. PubMed ID: 28827574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycomb YY1 is a critical interface between epigenetic code and miRNA machinery after exposure to hypoxia in malignancy.
    Infante T; Mancini FP; Lanza A; Soricelli A; de Nigris F; Napoli C
    Biochim Biophys Acta; 2015 May; 1853(5):975-86. PubMed ID: 25644713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
    Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
    Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance.
    Hendrickson DG; Hogan DJ; Herschlag D; Ferrell JE; Brown PO
    PLoS One; 2008 May; 3(5):e2126. PubMed ID: 18461144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells.
    Li CF; Tsai HH; Ko CY; Pan YC; Yen CJ; Lai HY; Yuh CH; Wu WC; Wang JM
    Mol Cancer Ther; 2015 Nov; 14(11):2623-33. PubMed ID: 26358750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer.
    Chuang CH; Wang WJ; Li CF; Ko CY; Chou YH; Chuu CP; Cheng TL; Wang JM
    Cell Death Dis; 2014 May; 5(5):e1220. PubMed ID: 24810056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
    Tang D; Sivko GS; DeWille JW
    Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC1/HDAC3 modulates PPARG2 transcription through the sumoylated CEBPD in hepatic lipogenesis.
    Lai PH; Wang WL; Ko CY; Lee YC; Yang WM; Shen TW; Chang WC; Wang JM
    Biochim Biophys Acta; 2008 Oct; 1783(10):1803-14. PubMed ID: 18619497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1.
    Yuan X; Ma R; Yang S; Jiang L; Wang Z; Zhu Z; Li H
    Cell Cycle; 2019 Jul; 18(14):1660-1669. PubMed ID: 31204563
    [No Abstract]   [Full Text] [Related]  

  • 20. Imatinib induces demethylation of miR-203 gene: an epigenetic mechanism of anti-tumor effect of imatinib.
    Shibuta T; Honda E; Shiotsu H; Tanaka Y; Vellasamy S; Shiratsuchi M; Umemura T
    Leuk Res; 2013 Oct; 37(10):1278-86. PubMed ID: 23953880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.